← Open Payments lookup

KARYSS HEAD: Open Payments

NPI 1669125043 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,846 in 58 payments from 18 companies in 2025. Trend: 2023 $1,144 · 2024 $736 · 2025 $2,846

Food & beverage: $2,846
CompanyPaymentsAmount
Novo Nordisk Inc9$544
Lilly USA, LLC4$491
ABBVIE INC.13$463
Bayer Healthcare Pharmaceuticals Inc.7$234
AstraZeneca Pharmaceuticals LP3$174
Kowa Pharmaceuticals America, Inc.9$149
Dexcom, Inc.1$143
GlaxoSmithKline, LLC.1$123
Amgen Inc.1$123
Phathom Pharmaceuticals, Inc.2$117

Products named: Wegovy, VRAYLAR, KISUNLA, Kerendia, QULIPTA, ZORYVE, AIRSUPRA, Dexcom G6 Transmitter.

Industry payments across TX — which companies pay providers there.